Outcomes in Acute Ischemic Strokes Presenting with Disabling Neurologic Deficits without Intracranial Vascular Occlusion
Autor: | Sarah Tymchuk, Andrew M. Demchuk, Matthew Boyko, Rohit Bhatia, Gopukumar Kumarpillai, Nandavar Shobha, Eric E. Smith |
---|---|
Rok vydání: | 2011 |
Předmět: |
Male
medicine.medical_specialty Comorbidity Brain Ischemia Modified Rankin Scale Occlusion medicine Humans Thrombolytic Therapy Stroke Aged Retrospective Studies Computed tomography angiography Aged 80 and over medicine.diagnostic_test business.industry Age Factors Magnetic resonance imaging Retrospective cohort study Cerebral Infarction Odds ratio Cerebral Arteries Middle Aged medicine.disease Magnetic Resonance Imaging Confidence interval Cerebral Angiography Treatment Outcome Neurology Tissue Plasminogen Activator Acute Disease Brain Damage Chronic Female Radiology Tomography X-Ray Computed business |
Zdroj: | International Journal of Stroke. 6:392-397 |
ISSN: | 1747-4949 1747-4930 |
DOI: | 10.1111/j.1747-4949.2011.00607.x |
Popis: | Background Patients with moderate to severe acute ischemic stroke without intracranial vessel occlusion are an intriguing subset of stroke patients. They pose diagnostic and therapeutic challenges to the physician. We sought to study these patients with an emphasis on their radiological and clinical outcomes. Methods This is a retrospective cohort study of ischemic stroke patients (NIHSS ≥ 6), with no intracranial vessel occlusion on computed tomography angiography within six-hours of symptom onset. Follow-up imaging – either computed tomography brain or magnetic resonance imaging – was performed within one- to seven-days. The primary outcome was modified Rankin Scale score ≤ 2 at three-months. Results In a database of 1308 patients, we identified 99 (7·6%) patients with NIHSS≥6 and no intracranial vessel occlusion on computed tomography angiography. The mean age was 67·8 ± 15·4 years and 60 (60·6%) were men. The median baseline NIHSS was nine (6–28). The initial computed tomography head was normal in 79 (79·8%) patients. Dramatic early clinical improvement at 24 h (NIHSS score ≤2 at 24 h or change between baseline and 24 h NIHSS score 15 points) was seen in 38 (38·4%) patients. Follow-up scans showed infarcts in 66 (66·7%) patients. Fifty (50·5%) patients received tissue plasminogen activator; one (2%) tissue plasminogen activator-treated patient developed symptomatic intracranial hemorrhage. At three-months; 59 (59·6%) patients were independent (modified Rankin Scale ≤2), 34 (34·3%) patients were dependent (modified Rankin Scale 3–5), and six (6·1%) were dead. The factors associated with the unlikelihood of good outcome were higher initial NIHSS (odds ratio 0·86 per additional point, 95% confidence interval 0·77–0·95, P = 0·003), and older age (odds ratio 0·95 per additional year, 95% confidence interval 0·92–0·98, P = 0·004). Conclusion Stroke without intracranial occlusions are not a benign entity. Factors that are independently associated with decreased likelihood of a good outcome are higher baseline NIHSS, and older age. Treatment with tissue plasminogen activator is not a predictor of outcome. |
Databáze: | OpenAIRE |
Externí odkaz: |